Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-25-001686
Filing Date
2025-11-12
Accepted
2025-11-12 16:30:33
Documents
67
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdio_10q-093025.htm   iXBRL 10-Q 1036924
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 8476
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 8123
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 5387
5 EXHIBIT 32.2 ex32x2.htm EX-32.2 5004
  Complete submission text file 0001079973-25-001686.txt   5282363

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdio-20250930.xsd EX-101.SCH 41396
7 XBRL CALCULATION FILE cdio-20250930_cal.xml EX-101.CAL 44029
8 XBRL DEFINITION FILE cdio-20250930_def.xml EX-101.DEF 163736
9 XBRL LABEL FILE cdio-20250930_lab.xml EX-101.LAB 272732
10 XBRL PRESENTATION FILE cdio-20250930_pre.xml EX-101.PRE 241953
69 EXTRACTED XBRL INSTANCE DOCUMENT cdio_10q-093025_htm.xml XML 961534
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41097 | Film No.: 251473430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)